VEGF-induced cell migration of human umbilical vein endothelial cells inhibitors (Harvard University/Harvard University Office of Technology Development)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameVEGF-induced cell migration of human umbilical vein endothelial cells inhibitors (Harvard University/Harvard University Office of Technology Development)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVascular endothelial growth factor receptor antagonists

TargetsVascular endothelial growth factor receptor

Therapy Area/IndicationsInflammationWet age-related macular degenerationNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHarvard University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHarvard University

Active IndicationsN/A

Inactive IndicationsInflammationWet age-related macular degenerationNeoplasms

Other Information

ATC CodeN/A